Pharmacy Friends is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future, and most importantly, what it means to you.
Prime Therapeutics / Magellan Rx
In this episode, you'll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology. Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible. Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. www.primetherapeuitics.com ChaptersDefining precision medicine (08:50)Evaluating real-world operational process of biomarker testing (14:36)Turnaround times are crucial (17:40)A patients view into the importance of time (24:39)Technology and process aid in time and process (29:30)Helping bridge knowledge gaps for providers and payers (33:55) The focus is on Precision Oncology right now (37:00)Precision medicine in other disease categories (40:09)Future of precision oncology is bright (42:07) References Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020. Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054. MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color. Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.
And here we are, at the Academy of Managed Care Pharmacy Annual for a 2nd year in row for a special “on the road” episode of Pharmacy Friends. This year, AMCP is in Houston with more than 6,000 managed care pharmacy and health care industry professionals in attendance. And thought leaders from Prime Therapeutics are also on hand to present 7 research posters and several education sessions based on our integrated medical and pharmacy claims data. This episode will help you gain clarity on the real-world impact of GLP-1 drugs, understand how predictive modeling can help identify members enrolled in Medicare Part D at risk of large increases in prescription drug spending, and other trends shaping the health care industry.We also have two up and coming researchers share their experience taking their first steps in the managed care space and their careers. (00:00) Introduction(01:05) 2024 JMCP “Article of the Year” Award for Excellence(06:46) Latest GLP-1 research(15:56) Accelerated Drug Approval Program (28:00) PBM and Medical Pharmacy Industry Trends(41:17) Medicare Member Drug Cost Predictive Model: Creation and Feature Engineering (50:32) Advancing Health Equity in Food Allergy Prevention and Treatment: Bridging Gaps in Care and Knowledge(55:22) Legislative Impacts on Site of Service: What is the Big Deal?(1:00:07) The next generation of managed care professionals
Managed care pharmacy is the practice of using real-world evidence to help patients get the right medications at the right cost. At Prime Therapeutics, the dedicated researchers who use studies to identify trends and recommend programs that improve overall health outcomes are members of the elite group called the health outcomes and research teams. Listen to explore Prime's research room and hear from these experts about how they work so they can help Prime provide care like they would want for their loved ones. Be sure to follow Pharmacy Friends on your favorite podcast platform and tune in on April 4 to hear from more researchers as they dive into the data they are presenting at AMCP Annual.
It's not every day you get to listen to a conversation about health care artificial intelligence, 3D printed medicines and not so futuristic ways of simplifying not only the pharmacy experience but the entire health care industry. George Van Antwerp, industry veteran and Prime's new SVP of product innovation, gives you insights into how he believes changes in consumerism is one of the leading reasons why he believes the health care industry needs to evolve. For more about George's insights, read his Pharmacy in 2050 article published in the Journal of the American Pharmacists Association.Pharmacy Friends episodeswww.primetherapeutics.comMore Prime Therapeutics news
This episode uncovers what it's like to investigate fraudulent pharmacies and why it matters for everyone involved. We have an impressive guest for you today. Our host Maryam Tabatabai, talks with Prime's special investigation unit leader Mitchell Scott and right out of the gate he describes how he wanted to broaden his horizon to help people in ways he never thought of before. He gives you insight into how his SIU team at Prime works to protect clients, members and employees from people looking to take advantage of others through the health care system. And that's not it, he touches on how ALL of his team's decisions are based on one simple thought, saving one life is all it takes for our actions to matter – and that is what they do best – providing the care they would want for their loved ones. https://www.primetherapeutics.com More Pharmacy Friends episodes Prime's Special Investigations Unit: A rockstar team
Dr. Scott Roberts, an infectious disease expert from Yale University, is back with us to share information about updated CDC guidelines for RSV vaccinations in a variety of populations. He also talks about how our nation's health care systems seem to be much better equipped this RSV season. Finally, you'll come away with a better understanding of what everyone can do to help prepare for this RSV season. Pharmacy Friends Rewind: Last winter, we talked with Dr. Roberts about the new frontier of RSV vaccines. We chatted about access issues, along with RSV impact and risk factors for all populations. Give it a listen. CDC: RSV informationwww.primethrapeutics.comAll Pharmacy Friends episodes Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen.
Millions of Americans took to voting booths to decide who will be the next president of the United States and here we are, the morning of Nov. 7, just two days after the historic election, to talk with two experts from the Prime Therapeutics government affairs team about the overall election and possible impact to our country's health care system. Host, Maryam Tabatabai, has a conversation with Caitlin Berry and Julie Cantor-Weinberg about the significance that these results may have in America's history and how this election could impact the health care industry. Our podcast "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you. Ways to listen Amazon Music | Apple | Spotify | YouTube About Prime Therapeutics Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we're reimagining pharmacy solutions to provide the care we'd want for our loved ones. We challenge the way it's always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. Follow us on social: https://www.linkedin.com/company/prime-therapeutics/ https://www.youtube.com/user/PrimeTherapeutics https://x.com/Prime_PBM
As we close out October and American Pharmacist Month, we have a special Power of People episode of Pharmacy Friends celebrating all pharmacists. Hear from our host Laura Spitzack and three of Prime's bright pharmacists about how they see the expanding role that a licensed pharmacist can have in addressing public health challenges. From working with technology partners to leaning into giving back to the younger generation, you will hear how they are having a hand in reshaping patient care and improving health outcomes. Our podcast "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most importantly, what it means to you. Ways to listen Amazon Music | Apple | Spotify About Prime Therapeutics Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we're reimagining pharmacy solutions to provide the care we'd want for our loved ones. We challenge the way it's always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. Follow us on social https://www.linkedin.com/company/prime-therapeutics/ https://www.youtube.com/user/PrimeTherapeutics https://x.com/Prime_PBM
It's been more than 2 years since the monumental Inflation Reduction Act bill passed. The bill offers opportunity for financial relief for millions of people with Medicare by improving access to affordable treatments. And today, we're here to talk about how Prime is positioning ourselves to put people first and deliver flexible government health care programs that drive affordability and enhance the member experience. Our host, Maryam Tabatabai, sits down with Prime's government programs and compliance experts Jason Moore and Angela Leroux for a conversation about the Inflation Reduction Act and why it's an important part of any government programs strategy. You'll get a glimpse into Prime's Center of Excellence, hear what Medicare members should be thinking about during open enrollment, and discover what health plans should expect in 2025 as the largest provisions go into effect. All Pharmacy Friends episodes More information: https://www.primetherapeutics.com https://www.primetherapeutics.com/medicare-and-managed-medicaid About Prime Therapeutics Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we're reimagining pharmacy solutions to provide the care we'd want for our loved ones. We challenge the way it's always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. Today, we're talking with several leaders at Prime about how each is focusing their work on the three pieces of our newly formed framework. We want to help make medications more affordable, deliver an easy, transparent experience and, most importantly, help people achieve better health. Pt. 1 – The specialty pharmacy shift – Reimagining for success In this segment, you'll hear from Prime's Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You'll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey. As a bonus, Steve also talks about how Prime's new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive. Pt. 2 – Cell & gene therapy – The crossroads of sci-fi and reality The frontier of medicine is here, and we're talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space. Pt. 3 – Health tech horizons – Diverse voices, unified innovation In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You'll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. In this segment, you'll hear from Prime's Senior Vice President, Specialty and Clinical Solutions, about why high-cost specialty drugs continue to dominate the pipeline. You'll learn how Prime is making it easy for patients to access the specialty medicines they need, a simplified approach to a complex problem where we support patients in their journey. As a bonus, Steve also talks about how Prime's new brand represents our ambition to become an icon for change and innovation in pharmacy solutions. Get insights into how Prime is reshaping pharmacy benefits management in a way that is patient centric, more affordable and more intuitive.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. The frontier of medicine is here, and we're talking about cell and gene therapy. In this segment, VP of Clinical Strategy and Programs, Jim Rebello, discusses how medicines are causing a seismic shift and rewriting the way we treat conditions and the code to life itself. But these innovations bring a heavy price tag, so we dive into what Prime is doing to navigate this space.
In this special episode, we are on the road in New York City at our 21st annual Specialty Summit. More than 600 people have come to Times Square to listen to exceptional speakers, gain insight from insightful expert panels and network with the brightest minds in specialty. In this segment, Chief Information Officer, Dinesh Kandanchatha, dives into how technology plays a role in accelerating innovation to meet the moment for our customers. You'll hear about his interview with Bill Nye the Science Guy from their closing keynote session from our Specialty Summit, where attendees heard about the developments in artificial intelligence and its potential impact on the health care industry and beyond.
GLP-1s and chronic weight management are two of the hottest topics in the medical industry. There isn't nearly enough content devoted to weighing all the variables associated with them, which our experts aim to address. In this episode of the Pharmacy Friends podcast, “Weight management – a holistic journey,” our experts discuss Prime's four primary tenants of practice for chronic weight management and how they play a role in ensuring any recommendations are rooted in the evidence focusing on improving patient adherence and persistence to treatment and driving value. Host, Maryam Tabatabai, vice president for clinical information at Prime Therapeutics, is joined by Pat Gleason PharmD, BCPS, FCCP, FAMCP, assistant vice president, health outcomes at Prime Therapeutics and Dariush Mozaffarian, M.D., Dr.P.H., Tufts University. Developing a holistic GLP-1 strategy Clinical Insights - Weight Management -- a holistic journey All Pharmacy Friends episodes
At Prime, we strive to provide the same care we would want for our loved ones. This purpose extends beyond our employees to encompass our members, clients and communities. In today's Power of People edition of Pharmacy Friends, we talk about how our employees help goes beyond our work in health care. On any given day, Prime's people can be found serving others in the communities where we live and work. Kerry Florian, vice president, total rewards, talks about Prime's community giving program, PrimeCares, which brings employees together to donate, volunteer and participate in community events. She also talks about working with our communities to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger through the Prime Together Foundation. And today's guest Becky DeRosia, senior development officer, Hennepin Healthcare Foundation, talks about their great purpose of healing and enriching life in our community and how organizations like the Prime Together Foundation are instrumental in their work. Corporate social responsibility PrimeCares PrimeTogether Foundation WATCH: PrimeTogether Foundation + Hennepin Healthcare Foundation + Faith support for families experiencing trauma offers comfort, builds trust in health care system
A Power of People edition. In today's episode, Many Voices, One Purpose, you'll find out the true power of people and how Prime is an organization that continues to commit to diversity, equity and inclusion efforts. Our host Laura Spitzack, talks with Zabrina Watkins, Melissa Strong and Pat Milligan, about how we unite through common values to find our path, keep growing and fundamentally strengthen our culture and the value we bring to all our partners and the communities we are privileged to serve. You'll discover the true meaning behind "radical welcomeness," as they explore topics related to our DEI Council, Corporate Social responsibility and what's on the horizon. You will also hear how we unite as one culture, with one purpose, and foster partnerships to collectively craft a better, more equitable and inclusive future for our employees and the people we serve. 2023 Corporate Social Responsibility Report Our culture Power of People video series https://www.primetherapeutics.com/
Jazz-laden melodies are typically the sonic output of “The Big Easy” but this week, it's a special episode as we take you to the Academy of Managed Care Pharmacy (AMCP) Annual Meeting, which was in New Orleans. Leading researchers from Prime Therapeutics and Magellan Rx are at the show, and we talk with these health care experts from our Clinical and Health Outcomes teams who are using integrated medical and pharmacy claims data to evaluate real-world drug utilization, managed care pharmacy programs, and associated costs of care for a range of conditions, including weight loss, cardiovascular disease, cancer, and multiple sclerosis. And, in the spirit of our host city, we have a little fun with our guests and see how much they know about “The Big Easy.” We even had a drop in visit from Susan Cantrell, AMCP CEO, who talked with us about how AMCP is on the forefront of pharmacy trends, but also how the organization seeks to improve access to care and reduce costs, particularly as health care trends show that the pharmacy benefit is becoming more expensive. Dig into the research All newsroom content https://www.primetherapeutics.com/ Guests: Landon Marshall, principal, health outcomes research Ben Urick, senior principal, health outcomes research Yuqian Liu, senior director, clinical account services Kyle Thompson, principal, data scientist Nick Friedlander, clinical program pharmacist Pat Gleason, assistant vice president, health outcomes David Eckwright, senior director, clinical project and program management Kristen Reimers, senior vice president of specialty clinical solutions
This year marks the second AMCP Annual meeting where Prime and MRx have showed up as one organization. But what does it mean for our business to show up at a crucial trade event like this? We are joined by two of our leaders responsible for putting our best foot forward at AMCP Annual, Pat Gleason, Assistant Vice President of Health Outcomes, and David Eckwright, Senior Director of Clinical Project and Program Management, to tell us more.
We are fortunate to have Susan Cantrell, AMCP CEO, join us for a conversation on what this show means and how it continues to have an impact on the health care industry.
Four of the Prime/MRx studies presented at AMCP relate to glucagon-like peptide-1 agonist – or GLP-1 – drugs. Earlier analysis of real-world data showed low adherence and increased cost of care for individuals in the first year of GLP-1 therapy. Prime/MRx has been a leader in GLP-1 insights, and three studies at AMCP take a fresh look at the GLP-1 data as it relates to weight loss. We have Ben Urick, Health Outcomes Reseach Senior Principal from Prime/MRx, here to walk us through the research.
Cancer care represents a rapidly rising and disproportionate share of overall health care spend. Medically integrated dispensing has been associated with better outcomes, lower waste and better patient care experiences for members receiving. Recognizing this value, payers have developed integrated dispensing networks to supplement traditional dispensing sites; however, little information is available comparing total cost of care. During this conversation with Landon Marshall, health outcomes research principal at Prime/MRx, we take a closer look at the AMCP study, Medically Integrated Dispensing of Oral Oncolytics: Real-World Cost of Care Comparison to Traditional Dispensing.
We're about to hear about an award-winning research study. Recently, a number of generic multiple sclerosis medications supported by the American Academy of Neurology have become more widely available. Managed care pharmacists can aid individuals in transitioning to generic therapies, reducing total drug spend and member cost. But just how successful can this transition be? Prime/MRx researchers took a closer look, and Nick Friedlander, clinical program pharmacist with Prime/MRx, explains how transition may lead to remarkable savings and improved health outcomes.
A key aspect of what AMCP seeks to achieve is improved access to care, and our next study looks closely at the factors that may impact that access. Social determinants of health are the conditions in a person's environment that affect health, function, and quality-of-life outcomes and risks. These factors contribute to as much as 80% of variation in health outcomes. In this segment, Kyle Thompson, data scientist principal with Prime/MRx, talks about how the development of a Medicare member-specific medication nonadherence risk score, related to social determinants of health, can improve how a member manages medication and adheres to their doctors prescription.
The mission of the Academy of Managed Care Pharmacy is to enhance the quality and affordability of health care. Prime/MRx is likewise focused on this same mission, which is even more crucial when you consider a key category driving health care spend today are specialty drugs, which are typically injections or infusions that are self-administered or administered by health care professionals. We caught up with Kristen Reimers, clinical pharmacist and senior vice president, Specialty Clinical Solutions at Prime/MRx, to talk about some of the education sessions at AMCP that touch on this important business segment.
Nothing might matter more than getting new talented and bright pharmacists in our door to get hands-on experience of specialty and medical drug management from a managed care perspective. YuQian Liu, Senior Director of Clinical Account Services, talks about how our ASHP accredited residency program allows people interested in managed care pharmacy to build their careers. She talks about the importance of developing a firsthand understanding of medical and pharmacy benefit integration and strategy. And touches on the skills and mindset needed that helps kick-start careers as a managed care pharmacist.
In this special edition of Pharmacy Friends, Mostafa Kamal, Prime Therapeutics, President and CEO, joined Capital Rx's Chief Executive Officer AJ Loiacono and SVP of Marketing & Communications Michael Passanante on the Astonishing Healthcare Podcast by Capital Rx. They share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy and provide better care to patients across the country leveraging next-generation technology: JUDI®. Prime's Newsroom www.primetherapeutics.com All Pharmacy Friends episodes Capital Rx podcasts https://www.cap-rx.com/
Welcome to Pharmacy Friends – we bring industry experts to the same table to talk about what is happening in pharmacy today, what is coming, and most importantly, what it means to you. A hot topic in the health care industry is GLP1s and chronic weight management. In this last segment of our two-part episode, our experts discuss Prime's analysis of real-world integrated pharmacy and medical claims data. Hosting today's episode “The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information. Joining her are two experts, David Lassen, a clinic pharmacist and Prime's Chief Clinical Officer, who has strategic oversight of clinical services and support for customers. Pat Gleason, assistant vice president, leads Prime/MRx's health outcomes team which performs deep dives into research data. These three experts discuss how their data shows low adherence and increased costs in the first year and how they hope to see additional data to refine our guidance on GLP1s and chronic weight management approaches. The Skinny on GLP-1s: Part 1 Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year All Pharmacy Friends episodes https://www.primetherapeutics.com/
A hot topic in the health care industry is GLP1s and chronic weight management. In this first of a two-part episode, our experts discuss clinical evidence, drug information and appropriate patient selection for GLP1 use. Hosting The Skinny on GLP1s,” is Maryam Tabatabai, vice president for clinical information, and is joined are two experts, Olivia Pane, a clinical pharmacist at Prime/MRx, who is also a certified diabetes care and education specialist by helping manage and treat diabetes, weight gain and other chronic conditions. Carole Kerzic, a drug information, and pipeline clinical pharmacist at Prime/MRx, who has extensive expertise following emerging therapeutics and investigational drugs from pipeline to post-FDA approval. These experts discuss the role of lifestyle modification, upcoming drug pipeline decision and even tackle how celebrities and social media influencers have impacted the availability of these medicines. Check out our other GLP1 content David Lassen Shares Insights on Prime/MRx Analysis on GLP-1 for Weight Loss in New Video Real-world analysis of GLP-1a drugs for weight loss finds low adherence and increased cost in first year ------------------------------------------------------------------ More about Prime/Magellan Rx News and information
In this episode, Navigating the RSV vaccine frontier, join Maryam Tabatabai, PharmD, a clinical information expert at Prime/Magellan Rx, as she talks about the new frontier of RSV monoclonal antibodies and vaccines with Scott Roberts, MD, an infectious disease expert from Yale University, who is navigating RSV season both professionally and personally. In this episode, these thought leaders discuss why RSV is a current hot topic in the health care industry and how it's impacting both health care systems and patients who choose to get the vaccine. Listen to their discussion covering the CDC guidance on obtaining access, the impact and risk factors of the illness and vaccines in both pediatric and adult populations, along with some conversation about how RSV monoclonal antibodies and vaccines can be administered. Content in this podcast is for informational or educational purposes only, and does not substitute professional medical advice or consultations with health care professionals. Always seek advice from a physician or other health care providers with any questions you have regarding a medical treatment or condition before undertaking a new health care regimen. More about our company - https://www.primetherapeutics.com/ Newsroom - https://www.primetherapeutics.com/news/ Making pharmacy's future brighter - https://www.primetherapeutics.com/about/reimagine-pharmacy/ Join Prime - https://www.primetherapeutics.com/careers/
Discover how the brightest minds in oncology are illuminating the possibilities. Listen to Simone Ndujiuba, Oncology Clinical Strategy, and Innovation Director, and Dr. Joseph Leach Chief Medical Officer at Prime Therapeutics and Medical Oncologist at the University of Minnesota Physicians, join forces to discuss next-generation trends, cutting-edge technologies, and their captivating journey of becoming oncologists. *Prime Therapeutics does not practice medicine.
Hosted by Brian MacDonald, director of specialty clinical strategy at Magellan Rx Management, and joined by Kourteney Martinez, pharmacy engagement specialist at Blue Cross Blue Shield of Alabama.
Jonathan Magness, vice president of Medicare Part D operations sits down with Mark Santilli, senior director of clinical strategy and programs, to talk managed care, the future of pharmacy, and more!
Jonathan Magness, vice president of Medicare Part D operations sits down with Alaka'i Montalbo, senior manager of formulary management, to talk managed care, the future of pharmacy, and more!
Millions of Americans are diagnosed with Type 2 diabetes, a serious and expensive health condition. In this episode of Pharmacy Friends, Magellan Rx Medical Director, Dr. Marci Chodroff, moderates an engaging discussion on all things diabetes and the key to improving patient health and reducing healthcare costs. Joining Dr. Chodroff is Barb Corn, Vice President of Physician and Clinical Operations, and Dr. Arpeta Gupta, endocrinologist expert and Magellan Rx Physician Clinical Reviewer. If you would like to learn more about the CDC National Diabetes Prevention Program, check out these resources: National Diabetes Prevention Program Overview Diabetes Prevention Recognition Program Application Prediabetes Risk Test National DPP Coverage Toolkit
The field of oncology is rapidly changing and evolving, with treatment becoming more precise and the speed of innovation compounding each year. As more targeted therapies come to market, more patients have the hope of living a longer life. In this past record-setting year, more novel cancer medicines became available for the first time than in any year in history, and many of them employ immunology or precision biomarkers to transform the way patients are treated. On this episode of Pharmacy Friends, we're diving deep into precision medicine with Haita Makanji, Vice President of Clinical Strategy and Innovation at Magellan Rx, and Clynt Taylor, President of Trapelo. Trapelo offers the first, interoperable, decision-support platform used by oncologists, labs, and payers to inform testing and treatment, streamline workflow and facilitate real-time alignment in precision medicine. Listen and learn how precision medicine be maximized to give cancer patients the best possible outcomes. This episode is brought to you by the Magellan Rx Management Specialty Summit. After two years of virtual events, we're back in New York City, bringing you brilliant speakers, thought-provoking panels, in-person networking, and live music. Register now.
Ever wonder how you can truly motivate people to change their habits? How to get someone who would never take their medication to finally follow through with it? In this episode, we are bringing you an in-depth exploration of behavioral economics and how healthcare is transforming through technology. Sagar Makanji, Vice President of Clinical Strategy and Programs at Magellan Rx Management, is joined by Matt Loper, CEO, and Co-founder of Wellth. They dive into leveraging the science of behavioral economics to help people form new healthy habits and create lasting behavior change. Grab some tissues and check out the video they mention in the episode here: https://vimeo.com/654346180/24c1585f3a
We are diving into all things 340B on this episode. Julie Burns, our resident consultant healthcare whiz is joined by Kevin Denton, a certified 340B expert and pharmacy programs mastermind at Magellan Rx. Listen to this episode to learn about 340B and hear some fun, facts, and mythbusters.
Our latest Pharmacy Friends podcast episode is all about the “intangibles” (emotions & feelings) that have an impact on our overall health… and what we can do to address them for better outcomes. Listen to Magellan Rx Expert, Brian MacDonald, and Eden Brownell of mPulse Mobile discuss the impact of digital tools on patient wellbeing and adherence. Fun fact: Magellan Rx won mPulse's Most Innovative Program in 2021 for our digital engagement pilot to address social isolation and loneliness during the pandemic. Check out the story here.
It's Medicare Open Enrollment Season! Michelle Juhanson (aka Ms. Medicare) shares some tips for anyone aging into Medicare, enrolling in a new plan, or even staying with a current plan. Check out these resources discussed in the episode: Medicare Resources 2022 "Medicare & You Handbook Preview 2022 Health & Prescription Drug Plans
In the first episode of Pharmacy Friends, two Magellan Rx powerhouses, Meredith Delk and Stephanie Stevens, discuss all things customer experience, employee engagement, and leadership, including lessons learned and key takeaways that you don't want to miss.
© 2020-2025 Ivy Podcast Discovery LLC
